Home › Funds › AdvisorShares Investments LLC › NRXP

AdvisorShares Investments LLC position in NRXP

NRX PHARMACEUTICALS INC · Health Care

AdvisorShares Investments LLC reported holding 805,066 shares of NRXP (NRX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.4M, representing 0.30% of its reported portfolio and ranking #46 among its reported holdings. AdvisorShares Investments LLC has disclosed NRXP holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)805.07K sh
Reported value held$2.35M
Portfolio Weight0.30%
First reportedQ4 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AdvisorShares Investments LLC's NRXP position evolved

AdvisorShares Investments LLC first disclosed a stake in NRXP in Q4 2023 at 642,632 shares (US$296K). The position peaked in Q2 2026 at 659,018 shares, worth US$2.7M. Across 12 filings, AdvisorShares Investments LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 805,066 shares valued at US$2.4M — an increase of 146,048 shares quarter over quarter.. Notable position changes include a 82% trim in Q2 2024 (shares fell 31% over the following quarter), a 139% increase in Q4 2024 (shares fell 7% over the following quarter), a 57% increase in Q2 2026 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 642.63K $295.61K New
Q1 2024 614.79K $290.12K Reduce
Q2 2024 108.08K $278.86K Reduce
Q3 2024 130.09K $219.84K Add
Q4 2024 310.31K $682.69K Add
Q1 2025 286.80K $556.39K Reduce
Q2 2025 263.80K $859.98K Reduce
Q3 2025 342.14K $1.13M Add
Q4 2025 328.00K $888.89K Reduce
Q1 2026 420.47K $895.60K Add
Q2 2026 659.02K $2.70M Add
Q3 2026 805.07K $2.35M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NRXP and 13F data

NRXP (NRX PHARMACEUTICALS INC) is a Health Care company. 46 other funds we track also report a position in NRXP — the largest reported positions include B Group, Inc. (US$16.7M), SJBENEN ADVISORY, LLC (US$42K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NRXP

All NRXP fund holders →

FAQ

How long has AdvisorShares Investments LLC held NRXP?

AdvisorShares Investments LLC has disclosed NRXP holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is AdvisorShares Investments LLC's current position in NRXP?

As of Q3 2026, AdvisorShares Investments LLC holds 805.07K shares of NRXP (NRX PHARMACEUTICALS INC), valued at $2.35M, representing 0.30% of its reported portfolio and ranking #46.

Has AdvisorShares Investments LLC been buying or selling NRXP?

In the latest 13F filing (Q3 2026), AdvisorShares Investments LLC increased its position in NRXP. The position peaked in Q2 2026 at 659.02K shares.

Which other funds hold NRXP?

Other major institutional holders of NRXP include B Group, Inc., SJBENEN ADVISORY, LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.